Genetic testing may be useful for patients with depression Pharmacogenomic testing may help avoid unnecessary prescribing of antidepressants that can cause unwanted effects in patients. American scientists came to this conclusion.

Pharmacogenomic research allows you to determine how the genes of a particular patient will respond to drugs. It has now been established that this type of testing should be used when prescribing antidepressants, powerful drugs with a range of side effects.. In some patients with depression, they can provoke undesirable consequences..

It became clear how to give hopeless cancer patients a chance Researchers also found that patients undergoing genetic testing have more impressive treatment outcomes compared to those who are treated without such tests. Within 24 weeks of therapy, a group of patients with genetic testing was able to achieve a reduction in symptoms of depression, with the peak effect occurring at 12 weeks. Every patient in this study suffered from a major depressive disorder.. His symptoms included insomnia, loss of appetite, a feeling of longing, and thoughts of death or suicide..

For the first time in Russia, genetic testing will begin for newborns. The findings of this study should encourage medical psychotherapists to use pharmacogenetic tests when prescribing drugs for patients with depression.. This is another step towards the so-called targeted treatment, developed individually for each patient, the effectiveness of which, as practice shows, is always much higher..

https://www. medicalforum. en/.

Keywords:.